Index60 Identifies Individuals at Appreciable Risk for Stage 3 Among an Autoantibody-Positive Population With Normal 2-Hour Glucose Levels: Implications for Current Staging Criteria of Type 1 Diabetes.

Nathan, Brandon M; Redondo, Maria J; Ismail, Heba; Jacobsen, Laura; Sims, Emily K; Palmer, Jerry; Skyler, Jay; Bocchino, Laura; Geyer, Susan; Sosenko, Jay M

Nathan, Brandon M; Redondo, Maria J; Ismail, Heba; Jacobsen, Laura; Sims, Emily K; Palmer, Jerry; Skyler, Jay; Bocchino, Laura; Geyer, Susan; Sosenko, Jay M.

Afiliação

Nathan BM; University of Minnesota, Minneapolis, MN.
Redondo MJ; Baylor College of Medicine, Texas Children's Hospital, Houston, TX.
Ismail H; Indiana University School of Medicine, Indianapolis, IN.
Jacobsen L; University of Florida, Gainesville, FL.
Sims EK; Indiana University School of Medicine, Indianapolis, IN.
Palmer J; University of Washington, Seattle, WA.
Skyler J; University of Miami, Miami, FL.
Bocchino L; University of South Florida, Tampa, FL.
Geyer S; University of South Florida, Tampa, FL.
Sosenko JM; Mayo Clinic, Rochester, MN.

Diabetes Care ; 45(2): 311-318, 2022 02 01.

Article em En | MEDLINE | ID: mdl-34853027

Assuntos

Diabetes Mellitus Tipo 1; Autoanticorpos; Glicemia/metabolismo; Peptídeo C; Diabetes Mellitus Tipo 1/metabolismo; Glucose; Teste de Tolerância a Glucose; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Diabetes Care Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Mongólia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google